India’s Venus Remedies pioneers generic Ceftazidime-Avibactam launch in Indonesia
Venus Remedies wins Indonesia approval for first generic Ceftazidime-Avibactam combo.
Venus Remedies wins Indonesia approval for first generic Ceftazidime-Avibactam combo.
Docquity launches AI Engage for pharma, unlocking HCP behaviour data across Asia.
CBRE poll shows 57% of APAC investors plan more buys in 2026, offices lead.
IOI Properties readies Malaysia REIT for 2026, Singapore listing in 2027 with prime assets.
Sasseur REIT eyes Hong Kong, Southeast Asia for growth after turning down China asset.
Digital Realty acquires Cyberjaya hub, eyes 14MW expansion in Malaysia’s data surge.
New NextFin Asia fund adds direct capital to Catapult program for ASEAN inclusion fintechs.
Broker research says Indonesian banks look “more stable” in 2026, with cheaper funding but ongoing SME risks.
Research houses forecast mid‑single‑digit loan growth for Malaysian banks in 2026 after a year of “normalisation”.
OCBC posts slightly higher quarterly earnings as fee, markets, and insurance income offset weaker lending margins.